Ocrelizumab in multiple sclerosis: risks and benefits. [electronic resource]

By: Producer: 20120410Description: 1196-7; author reply 1197 p. digitalISSN:
  • 1474-547X
Subject(s): Online resources: In: Lancet (London, England) vol. 379
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Letter; Comment

There are no comments on this title.

to post a comment.